Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.
about
Hypoxic conditions stimulate the production of angiogenin and vascular endothelial growth factor by human renal proximal tubular epithelial cells in cultureHeme oxygenase-1 modulates the expression of the anti-angiogenic chemokine CXCL-10 in renal tubular epithelial cellsRole of Receptor Tyrosine Kinase Signaling in Renal FibrosisTipping the balance from angiogenesis to fibrosis in CKDIs inflammation the cause of pre-eclampsia?Fluorescent microangiography is a novel and widely applicable technique for delineating the renal microvasculatureHypoxia-inducible factors in the kidneyVascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritisAntiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetesExcess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsiaVascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db miceStimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis.Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.Transplantation-associated thrombotic microangiopathy: twenty-two years later.PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis.The role of endothelial cell injury in thrombotic microangiopathy.VEGF ameliorates tubulointerstitial fibrosis in unilateral ureteral obstruction mice via inhibition of epithelial-mesenchymal transitionUrinary and plasma levels of vasohibin-1 can predict renal functional deterioration in patients with renal disorders.Angiogenesis and chronic kidney disease.Platelets are not critical effector cells for the time course of murine passive crescentic glomerulonephritis.Renal involvement in preeclampsia: similarities to VEGF ablation therapyGlomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection.Hypoxia in renal disease with proteinuria and/or glomerular hypertension.SDF-1/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney disease.Role of VEGF in kidney development, microvascular maintenance and pathophysiology of renal disease.Thrombotic microangiopathy associated with sunitinib, a VEGF inhibitor, in a patient with factor V Leiden mutationPlatelets are relevant mediators of renal injury induced by primary endothelial lesionsBone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis.Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditionsEffects of Platelet-Rich Plasma (PRP) on a Model of Renal Ischemia-Reperfusion in Rats.Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease.The Vascular Endothelial Growth Factors-Expressing Character of Mesenchymal Stem Cells Plays a Positive Role in Treatment of Acute Lung Injury In Vivo.Intermedin ameliorates vascular and renal injury by inhibition of oxidative stressVEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injuryMechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.Hypoxia-inducible factor signaling in the development of tissue fibrosisRenal hypoxia and dysoxia after reperfusion of the ischemic kidney.Alteration of microvascular permeability in acute kidney injury
P2860
Q24305206-91B59195-220F-4357-9E3E-F46EFBA44516Q24322029-93A6D7BE-5816-41C3-BF82-08DBA712E7C9Q26743407-0896CEDD-458D-423F-860B-29A50CE1F81AQ26796634-1F533C92-AEC5-48B9-B947-9CB3B08251FFQ27007059-25B70656-548C-4A89-B292-9DC1704EE724Q27320632-E219A426-FFA6-45BB-BCCF-0B4FFAD0D0FEQ28303287-FD38A4C0-F6A9-425E-8426-E1FEF90CADA3Q28345296-DB42FAD3-6D4A-4D24-856D-582C1D8B3B5AQ28538183-F67A16C1-2C67-46F6-82EA-32C1ECAD53C1Q29615916-E188F15B-9249-4DAC-9716-5B0D2CCED118Q31159383-628EC9EF-95BD-43CC-A968-D8CB51AEE18DQ33209298-FC089658-FA22-4589-9035-11DC34236233Q33251433-37E43211-04F3-4746-96EC-B67F4D769F93Q33345369-0D86C9F2-B7B0-453D-ACB2-BA0899E5715BQ33348441-EF797D1B-9B83-4E98-9CD5-BBC0EAEA3919Q33391882-6337EB53-7AFD-4B50-BD3B-BF0FC918BD3EQ33566806-B13BCFA2-32C5-4191-9AB4-F55FE17C5227Q33733979-5EB035B7-98D1-4C7A-87B8-557AD69E6B4DQ34075013-47141E20-6284-459E-BA4F-57033C5BE4D2Q34332255-83999888-AFDB-45C6-8954-2CC6CF26F3C4Q34735646-6E3BE361-DF93-45EA-B354-31189416D004Q34835409-D86F38CA-13DB-41AC-923F-563925B9335DQ35083393-16D60E68-4552-434C-9139-DBDD512727D4Q35103473-92BA755D-BE4E-48AF-90EF-2782E4486005Q35123087-9767C9D1-B26D-4376-A02A-ADB96D06B51CQ35181953-5592C56C-25D3-413B-A36D-98A87E547CA6Q35573669-3BD5C704-45A8-4045-A49B-AB37E4292597Q35671848-AC56BFD0-F07C-4EBD-9F8B-389AC9F3D5C0Q35791750-FAFE816D-B27F-447D-ABA3-B8260518A54BQ35971694-88953F19-E3F7-42C8-A589-C4542419D1C3Q36110083-EDF71D08-C22D-47E7-9402-4E68087080A4Q36707530-962A56AB-E750-46EF-BA4B-08E52FF52F07Q36838665-CC7A03D4-17B0-4A01-857C-C0CFED673586Q36974071-64055565-F402-4E06-8838-4FBE8914742BQ37018402-1D398C65-DE5F-4276-AB09-4BC303E11242Q37018432-F27D655F-14F2-44C8-8726-BC69FA0376CCQ37136212-FA6210B6-F80E-4516-B47A-95B3D367F0C4Q37140405-7AFED5A2-BFD2-4E72-8CAD-DFD69F352150Q37167225-97BD88EA-43BF-4E9D-8AE4-603667EC22B6Q37304519-0F3E923B-BBCD-40DC-86D8-C2415D2A6210
P2860
Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Vascular endothelial growth fa ...... al thrombotic microangiopathy.
@ast
Vascular endothelial growth fa ...... al thrombotic microangiopathy.
@en
Vascular endothelial growth fa ...... al thrombotic microangiopathy.
@nl
type
label
Vascular endothelial growth fa ...... al thrombotic microangiopathy.
@ast
Vascular endothelial growth fa ...... al thrombotic microangiopathy.
@en
Vascular endothelial growth fa ...... al thrombotic microangiopathy.
@nl
prefLabel
Vascular endothelial growth fa ...... al thrombotic microangiopathy.
@ast
Vascular endothelial growth fa ...... al thrombotic microangiopathy.
@en
Vascular endothelial growth fa ...... al thrombotic microangiopathy.
@nl
P2093
P1433
P1476
Vascular endothelial growth fa ...... al thrombotic microangiopathy.
@en
P2093
Breiteneder-Geleff S
Jefferson JA
Johnson RJ
Kerjaschki D
P304
P356
10.1046/J.1523-1755.2000.00422.X
P407
P577
2000-12-01T00:00:00Z
P5875
P6179
1003123999